Identification of isoniazid mono-resistance is delayed despite whole genome sequencing M. Park (London, United Kingdom), M. Coleman (London, United Kingdom), L. Martin (London, United Kingdom), G. Russell (London, United Kingdom), A. Lalvani (London, United Kingdom), G. Satta (London, United Kingdom), O. Kon (London, United Kingdom)
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Park (London, United Kingdom), M. Coleman (London, United Kingdom), L. Martin (London, United Kingdom), G. Russell (London, United Kingdom), A. Lalvani (London, United Kingdom), G. Satta (London, United Kingdom), O. Kon (London, United Kingdom). Identification of isoniazid mono-resistance is delayed despite whole genome sequencing. 4201
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS) Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs Source: Eur Respir J, 57 (3) 2002338; 10.1183/13993003.02338-2020 Year: 2021
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing. Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020
Diagnostic of sensitivity mycobacterium tuberculosis strains to isoniazid and rifampicin by simultaneous identification of mutations in rpoB, katG, inhA and ahpC-oxyR genes with biological microchips Source: Eur Respir J 2006; 28: Suppl. 50, 379s Year: 2006
Mutation analysis and treatment outcomes of Isoniazid monoresistant tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Rapid genotypic assays for detection the rifampin and isoniazid resistance in M. tuberculosis strains and clinical specimens in Moldova Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
Detection of mutations associated with isoniazid and rifampicin resistance in M. tuberculosis isolates from Kazakhstan Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan Source: Eur Respir J 2009; 33: 368-374 Year: 2009
Detection of fluoroquinolone resistance associated mutations in Mycobacterium tuberculosis by use of sequencing and TaqMan probes Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Application of next-generation sequencing to detect MTB resistance to first- and second-line anti-TB drugs Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Latent tuberculosis (infection). Evaluation of a short course treatment with isoniazid, rifampin and pyrazinamid Source: Eur Respir J 2002; 20: Suppl. 38, 567s Year: 2002
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB Source: Eur Respir J, 57 (1) 2001796; 10.1183/13993003.01796-2020 Year: 2021